Molecular diagnostics provide faster, more accurate identification of mucormycosis and co-infections compared to traditional culture methods.
RT’s Three Key Takeaways:
- Diagnostic Accuracy: A large cohort study found that polymerase chain reaction (PCR) diagnostics for mucormycosis demonstrated nearly 99% specificity and recognized all clinically confirmed cases in the sample group.
- Co-infection Identification: PCR testing successfully identified simultaneous fungal infections, such as Aspergillus and Mucorales, which are frequently overlooked by conventional microbiology methods.
- Rapid Intervention: Molecular methods allow for earlier detection in both respiratory samples and blood, enabling healthcare providers to initiate targeted antifungal therapy more quickly.
Molecular methods, specifically polymerase chain reaction (PCR) diagnostics, allow for the direct detection of fungal genomes with higher sensitivity than conventional methods, according to research from the Medical University of Graz.
The research team, which included internist and infectious disease specialist Jürgen Prattes, infectious disease specialist Martin Hoenigl, and microbiologist Sarah Sedik, investigated how these methods can contribute to earlier and more reliable detection of dangerous infections. The findings indicate that molecular genetics could facilitate rapid detection, replacing time-intensive methods based on cultures and tissue examination.
“If a diagnosis cannot be made rapidly following infection, we waste valuable time—and often the opportunity to successfully treat it. With fungal infections, time means survival,” said Prattes, internist and infectious disease specialist at the Medical University of Graz, in a news release.
Improved Specificity in Respiratory Samples
In a large cohort study of bronchoalveolar lavage samples—samples from the lower respiratory airways—the team investigated 1,400 samples from more than 1,300 patients at risk of invasive fungal infections. The results showed that the PCR test exhibited a specificity of nearly 99%, yielding reliable positive results for the detection of mucormycosis.
The study also found that a negative PCR test is highly likely to rule out an actual infection, which is significant in clinical environments where quick decisions are required. Furthermore, PCR testing yielded positive results in a relevant number of cases in which conventional diagnostics were unable to detect mucormycosis.
Addressing Fungal Co-infections
The Graz data highlighted evidence of previously unrecognized Mucorales infections in patients already suffering from invasive aspergillosis.
“We see time and again that patients can have not just one but several fungal infections at the same time, which has direct therapeutic implications,” said Hoenigl, infectious disease specialist. “Without PCR, many of these mixed infections would potentially remain undiscovered.”
An international multicenter trial directed by the Graz working group confirmed these observations. In that investigation, PCR achieved a sensitivity of over 94% in the diagnosis of mucormycosis and identified numerous cases overlooked by routine diagnostics in both tissue samples and bronchoalveolar lavage.
The high number of co-infections is critical for therapy because not all antimycotics have the same effect on both groups of pathogens. “If we do not detect these co-infections, we do not treat the actual problem under certain circumstances,” said Prattes.
Blood Sample Analysis
The potential of PCR was also demonstrated in the analysis of blood samples. In cases where classic methods did not provide evidence of mucormycosis, Mucorales DNA was detected in the blood, including in patients with severe disease progression.
“This opens up an additional diagnostic level,” said Sedik, microbiologist. “Especially for critically ill patients, for whom invasive interventions, for example lung biopsy, are difficult or not currently able to be conducted, a blood test can provide critical evidence.”
The researchers concluded that PCR diagnostics have the potential to complement previous diagnostics by detecting infections earlier while offering a time advantage over conventional approaches.
